Yes valid point.
Most wont do the research, they are happy to be guided by what their local GP recommends, the poor and current std of care. They are accepting that surgery is the only inevitable course.
Yes our data will speak for itself, that's coming in my opinion, 008 6 month will provide further evidence in terms of the separation of data between the cohorts after 6 months has passed but it will also show us objective data via MRI and structural markers. JSW for example would be terribly exciting at this early stage, 12 month could possibly be even more telling (Placebo -v- 2 weekly dosing for instance).
The challenge from there is to work on the labelling, if the DMOAD data is being shown at anything more than base level statistical significance and its clinically meaningful then once we have a pathway to getting it on the label, that then will pave the way to read-out and finally our chance to negotiate with the payers. This phase, the negotiations, will be a whole lot easier and definitely exacting as we present our data and evidence to the payers and the medical associations. It is the powerful AMA for instance that will eventually send out those memos to each and every Doc in the country saying we are the new std of care.
Its then that attitudes will chance and patients will flock.
My thoughts
- Forums
- ASX - By Stock
- PAR
- PAR Broker Data
PAR Broker Data, page-167
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $84.05M |
Open | High | Low | Value | Volume |
25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 9700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 0.240 |
4 | 64258 | 0.235 |
8 | 113649 | 0.230 |
5 | 71572 | 0.225 |
5 | 55537 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 1600 | 1 |
0.260 | 62000 | 2 |
0.265 | 66950 | 4 |
0.270 | 35288 | 4 |
0.275 | 23636 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online